Literature DB >> 16230372

Molecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancer.

Britta Weigelt1, Zhiyuan Hu, Xiaping He, Chad Livasy, Lisa A Carey, Matthew G Ewend, Annuska M Glas, Charles M Perou, Laura J Van't Veer.   

Abstract

Microarray analysis has been shown to improve risk stratification of breast cancer. Breast tumors analyzed by hierarchical clustering of expression patterns of "intrinsic" genes have been reported to subdivide into at least four molecular subtypes that are associated with distinct patient outcomes. Using a supervised method, a 70-gene expression profile has been identified that predicts the later appearance or absence of clinical metastasis in young breast cancer patients. Here, we show that distant metastases display both the same molecular breast cancer subtype as well as the 70-gene prognosis signature as their primary tumors. Our results suggest that the capacity to metastasize is an inherent feature of most breast cancers. Furthermore, our data imply that poor prognosis breast carcinomas classified either by the intrinsic gene set or the 70 prognosis genes represent distinct disease entities that seem sustained throughout the metastatic process.

Entities:  

Mesh:

Year:  2005        PMID: 16230372     DOI: 10.1158/0008-5472.CAN-05-2553

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  119 in total

1.  Surgical oncology: why biopsying metastatic breast cancer should be routine.

Authors:  Anand Sharma; Tim Crook; Alastair Thompson; Carlo Palmieri
Journal:  Nat Rev Clin Oncol       Date:  2010-02       Impact factor: 66.675

Review 2.  Genome organizing function of SATB1 in tumor progression.

Authors:  Terumi Kohwi-Shigematsu; Krzysztof Poterlowicz; Ellen Ordinario; Hye-Jung Han; Vladimir A Botchkarev; Yoshinori Kohwi
Journal:  Semin Cancer Biol       Date:  2012-07-04       Impact factor: 15.707

3.  Proteomic profiling identifies breast tumor metastasis-associated factors in an isogenic model.

Authors:  Paweena Kreunin; Chul Yoo; Virginia Urquidi; David M Lubman; Steve Goodison
Journal:  Proteomics       Date:  2007-01       Impact factor: 3.984

Review 4.  Molecular profiling in breast cancer.

Authors:  Shannon R Morris; Lisa A Carey
Journal:  Rev Endocr Metab Disord       Date:  2007-09       Impact factor: 6.514

5.  Aldolase B-Mediated Fructose Metabolism Drives Metabolic Reprogramming of Colon Cancer Liver Metastasis.

Authors:  Pengcheng Bu; Kai-Yuan Chen; Kun Xiang; Christelle Johnson; Scott B Crown; Nikolai Rakhilin; Yiwei Ai; Lihua Wang; Rui Xi; Inna Astapova; Yan Han; Jiahe Li; Bradley B Barth; Min Lu; Ziyang Gao; Robert Mines; Liwen Zhang; Mark Herman; David Hsu; Guo-Fang Zhang; Xiling Shen
Journal:  Cell Metab       Date:  2018-04-26       Impact factor: 27.287

Review 6.  Systems biology and genomics of breast cancer.

Authors:  Charles M Perou; Anne-Lise Børresen-Dale
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-02-01       Impact factor: 10.005

7.  Biological resonance for cancer metastasis, a new hypothesis based on comparisons between primary cancers and metastases.

Authors:  Dongwei Gao; Sha Li
Journal:  Cancer Microenviron       Date:  2013-11-10

Review 8.  The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis.

Authors:  M M Moasser
Journal:  Oncogene       Date:  2007-04-30       Impact factor: 9.867

9.  Epigenetic contributions to cancer metastasis.

Authors:  David I Rodenhiser
Journal:  Clin Exp Metastasis       Date:  2008-04-02       Impact factor: 5.150

10.  Comparison of expression profiles of metastatic versus primary mammary tumors in MMTV-Wnt-1 and MMTV-Neu transgenic mice.

Authors:  Shixia Huang; Yidong Chen; Katrina Podsypanina; Yi Li
Journal:  Neoplasia       Date:  2008-02       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.